Bcl10 [SN74-04] Antibody
Bcl10, also designated CIPER, c-CARMEN and mE10, was first identified as a gene truncated or mutated in MALT B cell lymphomas and other tumor types. Bcl10 is homologous to the equine herpesvirus-2 E10 gene and, like E10, it contains an N-terminal caspase recruitment domain (CARD) . Expression of Bcl10 has been shown to induce NFκB activation in a NIK-dependent pathway, and research indicates that the CARD domain is essential for this activation; although in a separate study, Bcl10 by itself did not induce JNK or NFκB activation. Overexpression of Bcl10 has been shown to induce apoptosis in a manner dependent on CARD-mediated oligomerization. Bcl10 has also been shown to play a role in processing of caspase-9 to its active dimer. Other studies have shown that Bcl10 is not mutated in many human tumors and lymphomas.
Product Specifications
Immunogen
Recombinant protein
Antibody Type
Primary Antibodies
Product Name Synonym
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-Uteroglobin/Scgb1a1 Antibody Picoband® Fluoro594 Conjugated
Lentiviral human GMFB shRNA (UAS) - Lentiviral human GMFB shRNA (UAS, RFP) plasmid
